FindTrial
Sign In

Research on the Mechanistic Role of the Pseudogene RPLP0P6/miR-497-5p/RPL32 Axis in Regulating Tumor Cell Stemness and Facilitating the Progression of Hepatocellular Carcinoma

Research on the Mechanistic Role of the Pseudogene RPLP0P6/miR-497-5p/RPL32 Axis in Regulating Tumor Cell Stemness and Facilitating the Progression of Hepatocellular Carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116071
Enrollment
Unknown
Registered
2026-01-05
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cancer

Interventions

Liver Cancer Observation Group:None

Sponsors

The First Hospital Of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Hepatocellular carcinoma; 2.All staging phases of hepatocellular carcinoma; 3.There was no previous history of tumors or significant organ damage;

Exclusion criteria

Exclusion criteria: 1.Do not meet the inclusion criteria; 2.Functional failure of vital organs; 3.After the pathological diagnosis is completed, those with a relatively small amount of remaining specimens;

Design outcomes

Primary

MeasureTime frame
The expressions of the pseudogene RPLP0P6, miR-497-5p, and RPL32;—

Countries

China

Contacts

Public ContactGuoxin Hou

The First Hospital Of Jiaxing

gxhou91@163.com+86 18457351876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026